Looking for a company with steady earnings growth and a share price that has outpaced the S&P 500 over the past decade? Stryker Corporation (NYSE: SYK ) would certainly be worth a look: Robert F. Abbott has been investing his family's accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Airdrie, Alberta, Canad ...

Stryker Corporation (SYK) has witnessed substantial gains in the year-to-date period. Shares of the company have rallied 18.6% compared with 13.4% growth of the industry. The S&P 500 Composite has risen 20.1% during the same time frame. With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for investors at the moment. Headquartered in Kalamazoo, MI, Stryker is one of the world's largest medical device companies operating in the glob ...

Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report its third quarter 2024 financial results on Tuesday, October 29, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the quarter ended September 30, 2024. Stryker will host a webcast at 4:30pm ET on Tuesday, October 29, to discuss results for the third quarter. The webcast can be ...

Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. "The acquisition of Vertos Medical enhances our unique, non-surgical solutions for interventionalists addressing chronic lower back pain, while broadening our presence in ambulatory surgery centers," said Andy Pierce, Group President, MedSurg and ...

PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition further strengthens Stryker's commitment to neurotechnology through tumor and stroke care. ICH, or bleeding in the brain caused by a ruptured blood vessel, is the ...

Stryker Corporation (SYK) announced that it has closed the previously-announced agreement to acquire care.ai, a privately held company specializing in artificial intelligence (AI)-assisted virtual care workflows, smart room technology and ambient intelligence solutions. This acquisition is likely to strengthen Stryker's healthcare IT and wireless medical device offerings, underscoring its commitment to delivering innovative solutions that can tackle key challenges in the healthcare industry. The deal should ...

Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions. "We welcome the care.ai team to Stryker and look forward to working together to accelerate our digital vision to provide customers with real-time, smart and connected decision-making tools that can enhance the ...

Stryker (SYK) recently announced the expansion of its Foot & Ankle portfolio with the introduction of two cutting-edge products — the Osteotomy Truss System ("OTS") and the Ankle Truss System ("ATS"). Acquired from 4WEB Medical, these new products are designed to enhance surgical precision and improve patient outcome. Both products will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting in Vancouver during Sept. 11-14, 2024. The addition of the ATS and the integration of Artelon dem ...

EMERYVILLE, Calif., Sept. 12, 2024 /PRNewswire/ -- Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases, today announced the appointment of Brent D. Lang, former Chairman and CEO of Vocera Communications, to its Board of Directors. Brent Lang, Former CEO of Vocera, joins Eko Health's Board of DirectorsBrent Lang, Former CEO of Vocera, joins Eko Health's Board of Directors Lang brings over three decades of healthcare and technology experience, having l ...

Financial Data and Key Metrics Changes - Stryker's Orthopedic business grew by approximately 8.5% in the first half of 2024, with a 9% growth when adjusted for selling days [2][3] - The company reported a mid-single-digit growth expectation for hip and knee procedures, up from low-single-digit pre-pandemic levels [6][8] - Pricing in orthopedics improved to less negative, with a first half decline of only 0.3%, compared to historical declines of 2% to 3% [11][12][15] Business Line Data and Key Metrics Changes - The Trauma and Extremities business outperformed expectations, with strong performance in core trauma and upper extremities [3][10] - Mako installations reached record levels in Q2, contributing to strong demand for orthopedic products [16][18] - The Pangea system in trauma is expected to provide additional growth, although its impact is still in early stages [55][58] Market Data and Key Metrics Changes - The demographic shift with more individuals over 65 years old is driving demand for hip and knee procedures, with 12,000 Americans turning 65 daily [6][7] - The capital environment remains healthy, with hospitals willing to invest in technology to improve patient care and efficiency [19] Company Strategy and Development Direction - Stryker is focused on a share-taking strategy across its orthopedic businesses, aiming to outperform market growth rates [66] - The company is committed to innovation and investment in its Mako platform, with plans to expand applications into shoulder and spine [23][25] - The acquisition of Vertos is part of Stryker's strategy to enhance its interventional spine offerings, targeting earlier treatment options for patients [74][75] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth, with expectations for a solid performance in the second half of 2024 and into 2025 [4][66] - The company is optimistic about the impact of new product introductions, including Mako for spine and shoulder, on future growth [66] Other Important Information - Stryker's customer solutions organization aims to enhance collaboration between its MedSurg and orthopedic divisions, driving growth in ambulatory surgery centers [69][70] - The company is actively pursuing tuck-in acquisitions to bolster its portfolio and maintain growth momentum [75] Q&A Session Summary Question: What drove the growth in Orthopedics? - Strong demand for products, particularly Mako technology, and new product introductions contributed to growth [3] Question: How are procedure volumes expected to trend? - Volumes are expected to continue increasing, driven by demographic changes and improved patient willingness for outpatient procedures [6][7] Question: What is the outlook for pricing in orthopedics? - Pricing has improved significantly, with a focus on building competency in pricing strategies [12][15] Question: How is Stryker addressing competition and market share? - The company is focused on a share-taking strategy and has seen success in its orthopedic businesses [21][60] Question: What is the expected impact of Mako on future growth? - Mako is expected to drive significant growth, with plans for new applications in spine and shoulder [25][36] Question: How does Stryker coordinate between MedSurg and orthopedics? - The company emphasizes collaboration through its customer solutions organization to align strategies and drive growth [69][70]